These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9853201

  • 1. Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.
    Halbe HW, de Melo NR, Bahamondes L, Petracco A, Lemgruber M, de Andrade RP, da Cunha DC, Guazelli CA, Baracat EC.
    Eur J Contracept Reprod Health Care; 1998 Sep; 3(3):113-20. PubMed ID: 9853201
    [Abstract] [Full Text] [Related]

  • 2. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
    Koetsawang S, Charoenvisal C, Banharnsupawat L, Singhakovin S, Kaewsuk O, Punnahitanont S.
    Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
    [Abstract] [Full Text] [Related]

  • 3. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
    Endrikat J, Müller U, Düsterberg B.
    Contraception; 1997 Mar; 55(3):131-7. PubMed ID: 9115000
    [Abstract] [Full Text] [Related]

  • 4. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control and tolerance.
    Endrikat J, Jaques MA, Mayerhofer M, Pelissier C, Müller U, Düsterberg B.
    Contraception; 1995 Oct; 52(4):229-35. PubMed ID: 8605781
    [Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive.
    Bilotta P, Favilli S.
    Arzneimittelforschung; 1988 Jul; 38(7):932-4. PubMed ID: 2974702
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone.
    Huber J, Foidart JM, Wuttke W, Merki-Feld GS, The HS, Gerlinger C, Schellschmidt I, Heithecker R.
    Eur J Contracept Reprod Health Care; 2000 Mar; 5(1):25-34. PubMed ID: 10836660
    [Abstract] [Full Text] [Related]

  • 7. Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 microg/ ethinylestradiol 15 microg and a 21-day regimen of desogestrel 150 microg/ethinylestradiol 20 microg.
    Eur J Contracept Reprod Health Care; 1999 Nov; 4 Suppl 2():17-25. PubMed ID: 14677621
    [Abstract] [Full Text] [Related]

  • 8. Contraceptive efficacy and acceptability of a monophasic oral contraceptive containing 30 microg ethinyl estradiol and 150 microg desogestrel in Latin-American women.
    Comparato MR, Yabur JA, Bajares M.
    Adv Contracept; 1998 Mar; 14(1):15-26. PubMed ID: 9587005
    [Abstract] [Full Text] [Related]

  • 9. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
    Hammerstein J, Daume E, Simon A, Winkler UH, Schindler AE, Back DJ, Ward S, Neiss A.
    Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
    [Abstract] [Full Text] [Related]

  • 10. A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
    Melis GB, Fruzzetti F, Nicoletti I, Ricci C, Lammers P, Atsma WJ, Fioretti P.
    Contraception; 1991 Jan; 43(1):23-31. PubMed ID: 1825970
    [Abstract] [Full Text] [Related]

  • 11. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
    Rekers H.
    Acta Obstet Gynecol Scand; 1988 Jan; 67(2):171-4. PubMed ID: 2972160
    [Abstract] [Full Text] [Related]

  • 12. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
    Benagiano G.
    Int J Fertil; 1989 Sep; 34 Suppl():31-9. PubMed ID: 2576255
    [Abstract] [Full Text] [Related]

  • 13. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
    Weber-Diehl F, Lehnert J, Lachnit U.
    Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
    [Abstract] [Full Text] [Related]

  • 14. A multicenter efficacy and safety study of an oral contraceptive containing 150 micrograms desogestrel and 30 micrograms ethinyl estradiol.
    Walling M.
    Contraception; 1992 Oct; 46(4):313-26. PubMed ID: 1486770
    [Abstract] [Full Text] [Related]

  • 15. A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel.
    Foidart JM, Wuttke W, Bouw GM, Gerlinger C, Heithecker R.
    Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):124-34. PubMed ID: 10943575
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 micrograms ethinylestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene.
    Serfaty D, Vree ML.
    Eur J Contracept Reprod Health Care; 1998 Dec; 3(4):179-89. PubMed ID: 10036600
    [Abstract] [Full Text] [Related]

  • 17. Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive.
    Ferguson H, Vree ML, Wilpshaar J, Eskes TK.
    Eur J Contracept Reprod Health Care; 2000 Mar; 5(1):35-45. PubMed ID: 10836661
    [Abstract] [Full Text] [Related]

  • 18. Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 microgram ethinyl estradiol combined with 150 microgram desogestrel or 75 microgram gestodene.
    Zichella L, Sbrignadello C, Tomassini A, Di Lieto A, Montoneri C, Zarbo G, Mancone M, Pietrobattista P, Bertoli G, Perrone G.
    Adv Contracept; 1999 Mar; 15(3):191-200. PubMed ID: 11019950
    [Abstract] [Full Text] [Related]

  • 19. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.
    Endrikat J, Düsterberg B, Ruebig A, Gerlinger C, Strowitzki T.
    Contraception; 1999 Nov; 60(5):269-74. PubMed ID: 10717778
    [Abstract] [Full Text] [Related]

  • 20. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Nov; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.